tirzepatide approval date FDA Approves Tirzepatide, A Potential Blockbuster Drug for Type 2 Diabetes Tirzepatide for Weight Loss |
Description
Medical eligibility depends on BMI, metabolic health, and individual risk factors evaluated by a qualified provider.
Trial registration number [NCT02648204][1]
Every ingredient and every batch of final product is independently tested for purity and potency
~400 Calories or Less so weight loss actually happens
